The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer

Show other versions (1)

Introduction: Breast cancers are divided into at least 4 sub Types on the Basis of gene expression profiles and expression of receptors as measured by IHC (Immunohistochemical). Triple negative breast cancer (TNBC) is more chemosensitive yet, it is much harder to detect than other sub types. At pres...

Full description

Bibliographic Details
Main Authors: Seyyed AsadoLah Mousavi, Efat Mashhadi, Masud Iravani, Ardeshir Ghavamzade
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2013-01-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Chemotherapy
CMF
TNBC
Online Access:http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/355/449

Similar Items

Similar Items